• Explore /
  • Poster
  • / Phase 3 randomized controlled trial comparing the effectiveness of dexamethasone in reducing cancer-associated fatigue in patients on palliative chemotherapy.

Phase 3 randomized controlled trial comparing the effectiveness of dexamethasone in reducing cancer-associated fatigue in patients on palliative chemotherapy.

Abstract Poster

Authors

Venkatraman Radhakrishnan

Venkatraman Radhakrishnan

Cancer Institute (WIA), Chennai, India

Venkatraman Radhakrishnan , Vamsi Vihari , Vidhya Gopalakrishnan , Venkata Siva Kiran Kumar Dasapathi , Perumal Kalaiyarasi Jayachandran , Swaminathan Rajaraman , Surendran Veeraiah

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session B

Track

Gastrointestinal Cancer,Gynecologic Cancer,Head and Neck Cancer,Quality of Care,Genetics/Genomics/Multiomics,Healthcare Equity and Access to Care,Healthtech Innovations,Models of Care and Care Delivery,Population Health,Viral-Mediated Malignancies

Sub Track

Advanced Disease

Clinical Trial Registration Number

CTRI/2018/08/015222

Citation

JCO Global Oncology 9, 2023 (suppl 1; abstr 134)

DOI

10.1200/GO.2023.9.Supplement_1.134

Abstract #

134

Poster Bd #

H9

Abstract Disclosures

Similar Posters

First Author: Venkatraman Radhakrishnan

First Author: Michelle Christine Janelsins

First Author: Eric Raymond

First Author: Vanita Noronha